ABBV vs MRK
ABBV and MRK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABBVAbbVie Inc. | MRKMerck & Co., Inc. |
|---|---|---|
| Market cap | $464.74B | $354.64B |
| P/E (TTM) | 74.3 | 115.0 |
| P/B | — | 8.46 |
| P/S | 7.6x | 5.5x |
| Dividend yield | 2.51% | 2.31% |
| Revenue | $61.16B(TTM) | $66.57B(TTM) |
| Revenue growth (YoY) | 8.6% | 1.3% |
| Net income | $6.31B(TTM) | $3.17B(TTM) |
| Earnings growth (YoY) | -1.2% | 6.6% |
| EPS, diluted | $3.54(TTM) | $1.25(TTM) |
| EBIT margin | 24.6% | 34.2% |
| ROE | — | 43.5% |
| ROIC | 18.6% | 21.6% |
| 1y total return | +23.8% | +81.4% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ABBV frente a MRK
| Métrica | ABBV | MRK |
|---|---|---|
| Valor final | $64.0K | $36.6K |
| Retorno total | +540.2% | +266.1% |
| CAGR | +19.7% | +13.4% |
| Volatilidad | 25.9% | 23.3% |
| Sharpe | 0.67 | 0.48 |
| Sortino | 0.93 | 0.71 |
| Caída máxima | -45.1% | -43.4% |
Basado en 2600 días de negociación comunes, 2016-05-12 → 2026-09-15 · tasa libre de riesgo 4.11% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)